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Polychlorinated biphenyls (PCBs), used in
commercial products and found in environ-
mental samples, are complex mixtures of 
congeners and their degradation products, a
feature potentially important in determining
the toxicity of a particular mixture. Con-
geners belong to two major groups: the copla-
nar PCBs and the ortho-substituted PCBs.
The toxic responses of coplanar PCBs are pre-
dominantly mediated by activation of the
aromatic hydrocarbon (Ah) receptors. Their
coupling and actions through Ah receptors
resemble those observed with 2,3,7,8-tetra-
chlorodibenzo-p-dioxin (TCDD), polychlori-
nated dibenzofurans (PCDFs), and related
substances (1–3). PCDFs, and to a lesser
extent TCDD, are found in increasing con-
centrations in aging PCB mixtures and in
samples from heated and/or burned PCBs
(2,4–6). The mono-ortho-substituted PCB
congeners also exhibit Ah receptor agonist
activity (7), but with lower potency than
coplanar congeners. The less chlorinated and
ortho-substituted PCBs (with two or more
ortho chlorines) have low or no afﬁnity for the
Ah receptors (8–10). However, they have a
proﬁle of hormone and neurotransmitter dis-
rupters that account for their toxicity (9,11).
The biochemical and toxic responses
induced by commercial PCBs are diverse
and include induction of drug-metabolizing
enzymes; thymic atrophy; immuno-, 
neuro-, dermal, and developmental toxicity;
porphyria; and other hepatotoxic effects (7).
The interference of PCBs with endocrine and
reproductive functions is well documented;
most studies have focused on fetal toxicity,
developmental malformation, a decrease in
reproductive ability, and multiple testicular
abnormalities (7,12,13). PCBs exhibit com-
plex estrogenic and antiestrogenic actions that
partially account for the observed effects on
reproductive functions (14–16). A few studies
have also addressed the effects of PCB con-
geners and mixtures on steroidogenesis in
gonadal and adrenal tissues (17–20). In rats,
intraperitoneal (ip) injection of a PCB con-
gener, 3,3´,4,4´,5,5´-hexachlorobiphenyl,
produces a marked reduction in plasma
testosterone concentration (21). A PCB mix-
ture containing only ortho isomers and
congeners also inhibits human chorionic
gonadotropin (hCG)-induced androgen pro-
duction in rat interstitial cells (22).
The aim of the present study was to eval-
uate the acute in vivo and in vitro effects of
Askarel, an Aroclor 1260-based transformer
ﬂuid, and to compare it with the effects of
two substitute fluids, the silicone oil-based
DC561 and the mineral oil-based ENOL C.
Our focus was on the effects of these ﬂuids on
rat testicular steroidogenesis. We compared
the effects of their ip and intratesticular (itt)
administration on serum testosterone and in
vitro testicular steroidogenesis 24 hr after
injection. We also examined the capacity of
postmitochondrial testicular fractions from
normal animals to produce steroid hormones
during a short-term in vitro exposure to
Askarel. The results of these investigations
indicate that Askarel, but not the substitute
ﬂuids, affects testicular steroidogenesis in vivo
and in vitro.
Materials and Methods
Chemicals. Askarel (commercial name
Pyralene) used in our experiments was sup-
plied by M. Vojinovic-Miloradov, Institute of
Chemistry, Novi Sad, Yugoslavia. Chemical
characterization of this sample, performed by
J. Cochran (Hazardous Materials Laboratory,
Champaign, IL, USA), S. Kapor (Laboratory
for Biophysics and Analytical Chemistry,
Zemun, Yugoslavia), and V. Djordjevic-Milic
(Institute for Health Protection, Novi Sad,
Yugoslavia), identiﬁed Pyralene as Askarel, an
Aroclor 1260-based transformer fluid with
10% trichlorbenzene. The silicone-based
transformer ﬂuid, Dow Corning 561 Silicone
Transformer Liquid (DC561) was manufac-
tured by Dow Corning Limited (Barry, South
Glamorgen, UK), and the mineral oil-based
transformer ﬂuid, ENOL C, was manufac-
tured by the Oil Rafinery Novi Sad,
Yugoslavia. Both samples were obtained from
S. Kapor. Antitestosterone-11 bovine serum
albumin (BSA; serum no. 250) and antiprog-
esterone-11BSA (serum no. 337) were sup-
plied by G. D. Niswender (Colorado State
University, Fort Collins, CO, USA). Medium
199 was purchased from GIBCO Labo-
ratories (Gaithersburg, MD, USA). We
obtained NADPH, NAD, cytochrome c,
BSA (fraction V), collagenase (type I), testos-
terone, ∆ 4-androstenedione, progesterone,
and pregnenolone from Sigma (St. Louis,
MO, USA). [1,2,6,73H(N)]-testosterone and
[1,2,6,73H(N)]-progesterone were purchased
from New England Nuclear (Brussels,
Belgium). We purchased Dextran T70 from
Pharmacia (Uppsala, Sweden) and charcoal
Norit A from Serva (Heidelberg, Germany).
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Articles
Polychlorinated biphenyl (PCB)-based transformer ﬂuids belong to a class of environmentally per-
sistent mixtures with known toxic effects. Here, we studied the acute effects of Askarel (which con-
tains Aroclor 1260) and two substitute transformer ﬂuids (the silicone oil-based DC561 and the
mineral oil-based ENOL C) on rat testicular steroidogenesis. Single intraperitoneal (ip; 10 mg/kg
body weight) or bilateral intratesticular (itt; 25 µg/testis) injections of Askarel markedly decreased
serum androgen levels 24 hr after administration. In acute testicular cultures from these animals,
chorionic gonadotropin-stimulated progesterone and androgen productions were severely attenuat-
ed. When itt was injected or added in vitro, Askarel inhibited 3β -hydroxysteroid dehydrogenase
(3β HSD), stimulated 17α -hydroxylase/lyase (P450c17), and did not affect 17β -hydroxysteroid
dehydrogenase in testicular postmitochondrial fractions. The ip-injected Askarel did not affect
3β HSD, but inhibited P450c17, suggesting that a more intensive metabolism of peripherally inject-
ed Askarel reduces the circulating levels of active ingredients below the threshold needed for inhibi-
tion of 3β HSD and generates a derivative that inhibits P450c17. In contrast to Askarel, itt-injection
(25 µg/testis) of DC561 and ENOL C did not affect in vivo and in vitro steroidogenesis. These
ﬁndings show the acute effects of Askarel, but not silicone and mineral oils, on testicular steroidoge-
nesis. Key words: 3β -hydroxysteroid dehydrogenase, androgen, P450c17, polychlorinated biphenyls,
progesterone. Environ Health Perspect 108:955–959 (2000). [Online 5 September 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p955-959andric/abstract.htmlTris (hydroxymethyl) aminomethane was
purchased from Bethesda Research Labo-
ratories (Bethesda, MD, USA). All other
reagents were of analytical grade.
Animals, treatments, and in vitro
steroidogenesis. Male Wistar rats, were raised
under controlled environmental conditions
(temperature 22 ± 2°C and 14 hr light/10 hr
dark) in our laboratory, with food and water
ad libitum; animals were used for experiments
at approximately 3 months of age. We pre-
pared the desired concentrations of trans-
former fluids by evaporating the required
amount of stock solution and dissolving it in
olive oil or saline. Rats were handled daily
during a 1-week acclimation period before
experiments and then treated with an ip injec-
tion of either vehicle (olive oil) or transformer
ﬂuid [10 mg/kg body weight (bw)], or with
an itt injection of either vehicle (saline) or
transformer ﬂuid (25 µg/testis), between 0800
and 0830 hr.
We conducted the experiments in accor-
dance with the principles and procedures of
the NIH Guide for the Care and Use of
Laboratory Animals (23), and the Local
Animal Ethical Committee of the Institute of
Biology. Animals were sacriﬁced by decapita-
tion 24 hr after injections, trunk blood was
collected, and serum samples were stored at
–20°C until analysis for testosterone and
dihydrotestosterone (T+DHT) content by
radioimmunoassay (RIA). Testes from control
and treated rats were quickly removed, decap-
sulated, weighed, and incubated individually
in vials containing 5 mL medium 199
enriched with 0.1% BSA and 20 ng/mL
hCG. The contents of the incubation vials
were gassed with 95% O2/5% CO2, and
incubation was carried out for 3 hr at 34°C in
a shaking water-bath (100 oscillations/min).
Incubation media was decanted and cen-
trifuged for 10 min at 1,500g, and individual
samples of supernatants were stored at –20°C
before measurement of androgen (T+DHT)
and progesterone levels by RIA.
Enzyme activities in postmitochondrial
fractions. To prepare the postmitochondrial
fractions from testicular tissue, testes were
decapsulated and homogenized in 50 mM
phosphate buffer containing 0.25 M sucrose
(pH 7.4), using a glass–glass homogenizer.
After centrifugation (4°C for 20 min at
1,500g), the supernatants were mixed with
dextran-coated charcoal to remove the
endogenous steroids (24). The samples were
centrifuged at 1,500g for 10 min, and super-
natants were further centrifuged at 12,000g
for 20 min. We estimated protein content in
postmitochondrial fractions by the Bradford
method (25), using BSA as a standard. The
desired concentrations of Askarel were
prepared by evaporating the necessary amount
of stock solution, dissolving it in 0.1 M
phosphate buffer, and adding it directly into
the corresponding reaction mixture.
We estimated 3β -hydroxysteroid dehy-
drogenase (3β HSD) activity through the
conversion of added pregnenolone to proges-
terone. The incubation solution, with a ﬁnal
volume of 2 mL, contained 25 µM preg-
nenolone, 135 µM NAD+, 100 mM phos-
phate buffer (pH 7.4), and 0.1 mL of the
postmitochondrial fraction (0.22 mg pro-
teins/tube). Mixtures were incubated for 10
min at 37°C in a shaking water-bath in an
atmosphere of 95% O2/5% CO2. We esti-
mated the 17α -hydroxylase/C17-20lyase
(P450c17) and 17β -hydroxysteroid dehydro-
genase (17β HSD) activities in postmitochon-
drial fractions by conversion of progesterone
to testosterone and ∆ 4-androstenedione to
testosterone, respectively (26). Brieﬂy, in the
ﬁnal volume of 0.25 mL, the incubation solu-
tion contained 10 µM steroid substrates, 1
mM NADPH, 0.1 M phosphate buffer (pH
7.4), and 0.1 mL postmitochondrial fractions
(0.35 mg proteins/tube). Mixtures were incu-
bated for 15 min at 37°C in a shaking water-
bath in 95% O2/5% CO2 atmosphere. 
We measured 3β HSD activity in the
presence of subsaturating concentration of
pregnenolone (the estimated Km = 8.43 ±
1.76 µM), whereas activities of P450c17 and
17β HSD were measured in the presence of
saturated concentrations of corresponding
steroid substrates. Selected incubation times
were within temporal linearity of the enzyme
activities (26,27). Enzyme reactions were ini-
tiated by adding 0.1 mL postmitochondrial
fractions and terminated by placing the tubes
in an ice-cold bath. The samples were stored
at –20°C until assayed for testosterone or
progesterone by RIA.
We measured NADPH-P450 reductase
activity in postmitochondrial fractions of
purified interstitial cells as the change in
absorbancy at 550 nm (28). Brieﬂy, rat testes
were decapsulated and enzymatically dis-
persed with collagenase according to
Anakawe et al. (29), with some modiﬁcation
(27). Interstitial cells were resuspended in 5
mL of 17 mM Tris, 140 mM NH4Cl solu-
tion (pH 7.2), and incubated for 10 min at
room temperature. This procedure elimi-
nates red blood cells and the interference of
hemoglobin. The cell pellets were washed
twice with medium 199-BSA and twice with
0.9% saline. Postmitochondrial fractions
were prepared as described above. We mea-
sured NADPH-P450 reductase activities in
0.1 M phosphate buffer-containing incuba-
tion mixtures (final volume 0.6 mL) con-
taining 0.2 mM NADPH, 1 mM KCN, 30
µM cytochrome c, 0.15 mg proteins from
postmitochondrial fractions, and increasing
concentrations of Askarel or buffer (con-
trols). The reactions were initiated by adding
NADPH, which was omitted from the
blanks (28,30). The millimolar extinction
difference between reduced and oxidized
cytochrome c was 21.2 at 550 nm.
Hormone assays. We estimated andro-
gens and progesterone levels in serum and
incubation medium by RIA. Each experi-
ment was run in a single assay. Precision of
androgen assay was 6 pg/tube; intra- and
interassay coefﬁcients of variation were 5.8%
and 7.5%, respectively. The antitestosterone
serum used in RIA showed a high cross-reac-
tivity with dihydrotestosterone (DHT), and
assay values for androgen production are
referred to as T+DHT concentrations. There
was no cross-reactivity of progesterone and
∆ 4-androstenedione with antitestosterone
serum in 152×  diluted samples used to esti-
mate androgen production in vitro. Precision
of progesterone assay was 6 pg/tube and
intra-assay and interassay coefﬁcients of vari-
ation were 6.8% and 10.7%, respectively.
Because antiprogesterone serum used in RIA
assay for progesterone cross-reacts with preg-
nenolone with a relative binding afﬁnity of
1.4%, additional tubes without postmito-
chondrial fractions and with pregnenolone
were also included, and progesterone produc-
tion was calculated after subtraction of these
blanks for pregnenolone.
To assess the possibility of cross-reactivity
between transformer ﬂuids and antiproges-
terone and antitestosterone sera used in our
RIA assay, we also incubated tubes containing
0.1 M phosphate buffer, corresponding
steroid substrate, and increasing concentra-
tions of transformer ﬂuids without postmito-
chondrial fractions. Transformer fluids did
not signiﬁcantly cross-react with antitestos-
terone serum (between 0.1% and 1%,
depending on added concentration). The
cross-reactivity between antiprogesterone
serum and transformers ﬂuids was < 1%. The
T+DHT and progesterone productions were
calculated after subtraction of corresponding
blanks for each transformer ﬂuid.
Statistical analysis. All results are
expressed as means ± SEMs. Statistical analy-
sis for data shown in Figures 1, 2A, 3A, and 4
was performed by Student’s t-test and Mann-
Whitney test, with p < 0.05 in both tests.
Data shown in Figures 2B and 3B and Tables
1 and 2 were analyzed by analysis of variance
(ANOVA), and post hoc comparisons
between means were made by Dunnett’s test,
with p < 0.05. 
Results
Both ip (10 mg/kg bw) and bilateral itt (25
µg/testis) injections of Askarel were associat-
ed with a significant decrease in serum
T+DHT levels 24 hr after treatments
(Figure 1A). The hCG-stimulated androgen
production by decapsulated testes from these
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experimental groups (Figure 1B), as well as
the progesterone production by the same
cultures (Figure 1C). These results indicate
that Askarel injected in vivo down-regulates
serum androgens and the capacity of testicu-
lar tissue to synthesize steroid hormones and
that this inhibition was independent from
the method of exposure (i.e., peripheral
versus intratesticular). 
To identify the metabolic steps affected by
Askarel, in further studies the activities of sev-
eral steroidogenic enzymes were examined in
testicular tissue. The conversion of preg-
nenolone to progesterone was used to measure
the activity of 3β HSD (see Materials and
Methods). As shown in Figure 2A, the activity
of this enzyme in testicular postmitochondrial
fractions was not changed by ip administra-
tion of Askarel (left panel). However, enzyme
activity was signiﬁcantly inhibited in postmi-
tochondrial fractions from itt-treated animals
(right panel). Askarel also decreased the con-
version of pregnenolone to progesterone when
added directly to the postmitochondrial frac-
tions of normal rats (Figure 2B). At the con-
centrations tested, this inhibition was not dose
related, suggesting a high sensitivity of
3β HSD to Askarel.
The conversion of progesterone to testos-
terone in postmitochondrial fractions was
also affected by Askarel injection (Figure 3).
In ip-treated animals, conversion was dra-
matically inhibited (Figure 3A, left panel). In
contrast, this metabolic step was slightly
stimulated in postmitochondrial fractions
from itt-injected animals (right panel).
Consistent with the itt treatment, Askarel
added in vitro stimulated the conversion of
progesterone to testosterone in a dose-depen-
dent manner (Figure 3B). In general, this
stimulatory action of Askarel could be medi-
ated by facilitating the P450c17 pathway,
which transforms progesterone to ∆ 4-
androstenedione, or by facilitating 17β HSD,
an enzyme that converts ∆ 4-androstenedione
to testosterone. Consistent with the first
hypothesis, Askarel added in vitro did not
affect the ∆ 4-androstenedione-supported
testosterone production (Table 1). 
The observed changes in the P450c17-
mediated androgen production could be
related to the direct effects of Askarel on
this enzyme, or could be indirect, through
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Figure 1. Effects of ip and itt injection of Askarel
on (A) T+DHT levels, (B) in vitro hCG (20 ng/mL)-
stimulated androgen, and (C) progesterone pro-
duction. Bars represent mean ± SEM in one from
three and four independent experiments for ip
and itt injections, respectively. The numbers
above the bars represent the number of animals
(A) and the number of testes (B, C). We used sep-
arate control animals for ip and itt experiments. 






































































































































Figure 2. Effects of Askarel on the conversion of
pregnenolone to progesterone in postmitochon-
drial fractions from (A) in vivo-treated animals
and (B) in vitro treatment. Bars in (A) represent
mean ± SEM, and the numbers above the bars
indicate the number of animals included. Data
points shown in (B) are mean ± SEM of six to
eight assay replicates in one of four similar exper-
iments, and postmitochondrial fractions were
obtained from two animals per experiment. 






































































Figure 3. Effects of Askarel on the conversion of
progesterone to testosterone in postmitochon-
drial fractions from (A) in vivo-treated animals
and (B) in vitro treatment. Bars in (A) represent
mean ± SEM, and the numbers above the bars
indicate the number of animals included. Data
points shown in (B) are mean ± SEM of six to
eight assay replicates in one of four similar exper-
iments, and postmitochondrial fractions were
obtained from two animals per experiment. 










































































Control Askarelstimulation of NADPH-P450 reductase
activity, an enzyme that mediates transport
of electrons needed for P450c17 activity. To
address the latter possibility, NADPH-P450
reductase activity was measured in postmito-
chondrial fractions of interstitial cell
preparations from adult rats 15 min after
incubation with Askarel. As shown in Table
2, Askarel increased the activity of NADPH-
P450 reductase when added at 11 ppm.
However, in concentrations that affected the
conversion of progesterone to testosterone,
Askarel was ineffective (Figure 3B), indicat-
ing that P450c17 was directly stimulated.
Samples of DC561 and ENOL C trans-
former ﬂuids were tested by the itt route of
administration, and results of these investi-
gations are presented in Figure 4. Both
transformer fluids had no effect on serum
androgen levels (Figure 4A) and hCG-stimu-
lated androgen production by decapsulated
testes (Figure 4B). Also, no changes in the
conversion of pregnenolone to progesterone
(Figure 4C), progesterone to testosterone
(Figure 4D), and ∆ 4-androstenedione to
testosterone (not shown) by postmitochon-
drial fractions were observed. This suggests
that the activities of 3β HSD, 17β HSD, and
P450c17 were unchanged in DC561 and
ENOL C-treated animals. 
Discussion
The potential toxic effects of PCB-containing
and PCB-free transformer ﬂuids on steroido-
genesis have not been studied previously.
However, several reports have addressed the
effects of variable PCB mixtures on steroido-
genic enzymes. For example, Aroclor 1248
down-regulates rat testicular steroidogenesis by
an acute inhibition of 3β HSD and P450c17
(31). This mixture contains 21% of trichloro-
biphenyl, 55% of tetrachlorobiphenyl, and
21% of pentachlorobiphenyl, each of which
have similar amounts of mono-ortho and di-
ortho congeners (32). In contrast, Aroclor
1254 does not alter the activity of P450c17 in
the microsomal fraction of guinea pig testes
when injected in vivo or added in vitro (20).
This commercial mixture of PCB congeners
contains about 2% of trichlorobiphenyl, 17%
of tetrachlorobiphenyl, 49% of pentachloro-
biphenyl, 29% of hexachlorobiphenyl, and
4% of septachlorobiphenyl (32).
Here we studied the acute in vivo and in
vitro effects of Askarel, an Aroclor 1260-
based transformer ﬂuid, and the two substi-
tute PCB-free transformer fluids, DC561
and ENOL C. Aroclor 1260 contains 47%
of hexachlorobiphenyl and 37% of hep-
tachlorobiphenyl, and between them more
than 85% of congeners with two or more
ortho-chlorines (32). Our results indicate that
Askarel inhibited rat testicular steroidogenesis
when administrated in vivo. Independently
of the mode of exposure (ip vs. itt), injection
of Askarel was accompanied by a strong
reduction of serum androgen levels. In paral-
lel to changes observed in blood, a signiﬁcant
inhibition of hCG-stimulated progesterone
and androgen production by decapsulated
testes was observed. 
We also measured the activities of several
steroidogenic enzymes in postmitochondrial
fractions of in vivo-treated animals by fol-
lowing the conversion of corresponding sub-
strate to a certain product (see Materials and
Methods). The effects of Askarel on steroid
conversion were complex. Similar to the
effects of Aroclor 1248 (31), Askarel also
inhibited 3β HSD activity in the postmito-
chondrial fractions from both itt-treated ani-
mals and when added in vitro. In contrast to
Aroclor 1248 (31) and Aroclor 1254 (20),
Askarel facilitated P450c17 activity in the
same experimental conditions. This facilita-
tion probably occurs through direct action
because NADPH-P450 reductase activity
was affected only in high Askarel concentra-
tions. Finally, 17β HSD, an enzyme that
converts ∆ 4-androstenedione to testosterone,
was not affected. Thus, it is likely that the
mixture of PCBs may or may not exhibit a
speciﬁc toxic effect, depending on the pres-
ence of a particular compound and mixture
of certain congeners.
Because the participation of aromatase, a
P450-dependent enzyme, on steroidogenesis
in whole cell testis homogenates and the
potential effects of Askarel on this enzyme
were not tested, we cannot exclude the impact
of this pathway on the estimated T+DHT
levels in our experiments. However, the ratio
of testosterone versus estradiol levels in adult
rat testes is more than 1,000 (33), suggesting
that aromatizaton as a possible pathway in
metabolism of testicular testosterone is of a
minor signiﬁcance in the 3-month-old ani-
mals used in our experiments. Also, TCDD
induced no effect on aromatase activity in rat
ovary, although it affected the activity of
P450c17 (34). Therefore, it is highly probable
that the impact of aromatase activity and the
potential modulation of its activity by Askarel
do not significantly affect T+DHT levels
measured in the whole cell testis homogenates
during 3-hr incubation period.
The effects of Askarel on steroid conver-
sion also depended on the type of administra-
tion. No inhibition of 3β HSD activity was
observed in ip-treated animals, whereas
Askarel inhibited this enzyme when injected
itt and added in vitro. In contrast, the conver-
sion of progesterone to testosterone was
inhibited in ip-treated animals, whereas
itt-treated animals and in vitro-added Askarel
stimulated conversion. Such differences could
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Figure 4. Effects of itt-injection of silicon oil-based
DC561 and mineral oil-based ENOLC transformer
fluids on (A) T+DHT levels, (B) in vitro hCG (20
ng/mL)-stimulated androgen production, (C) the
conversion of pregnenolone to progesterone, and
(D) progesterone to androgens in postmitochondrial
testicular fractions. Groups of rats were treated by
a bilateral itt-injection (25 µg/testis) of silicon or
mineral oil and animals were sacriﬁced 24 hr after
injections. Bars represent mean ± SEM. In (A) the
numbers above the bars represent the number of
animals; in (B), (C), and (D), the numbers above the
bars represent the number of testes or individual
testicular postmitochondrial fractions from control
and treated rats in one of two similar experiments.



























































































Table 1. The lack of in vitro effects of Askarel on
17β HSD activity in postmitochondrial testicular
fraction of normal adult rats.
Askarel (ppm)  ∆ 4A → T+DHT (ng/min/mg)
Controls 33.86 ± 0.15
0.0022 33.87 ± 1.02
0.022 34.33 ± 1.42
0.22 33.43 ± 1.08
2.22 34.48 ± 2.47
T+DHT production was estimated in the presence of ∆ 4-
androstenedione (∆ 4A). Values shown are mean ± SEM of
six to eight replicates in one of two similar experiments. 
Table 2. In vitro effects of Askarel on the NADPH-
P450 reductase activity in postmitochondrial frac-
tions of interstitial cells of normal adult rats.
Dose (ppm) Enzyme activity (nmol/min/mg)
0 (Controls) 2.66 ± 0.30
0.0022 2.65 ± 0.03
0.022 2.64 ± 0.04
0.22 2.60 ± 0.04
2.2 2.61 ± 0.05
11.0 3.26 ± 0.09*
NADPH-P450 reductase activity was measured in the pres-
ence of 30 µM cytochrome c and increasing concentra-
tions of Askarel, as described in “Materials and Methods.”
Values shown are mean ± SEM from six incubations for
each concentration in one of two experiments. *p < 0.05.be explained by a more intensive metabolism
of Askarel in the liver when injected ip, com-
pared to that after itt application. Thus, the
former difference may result from a reduction
in the circulating levels of active ingredients
present in Askarel below the threshold needed
for inhibition of 3β HSD. It is also known
that metabolism of PCBs results in the forma-
tion of various derivatives, many of which are
toxic (16), which may provide a rationale for
down-regulation of P450c17 activity in ip-
injected animals. 
Concentrations of Askarel used in our in
vitro studies were in the range of 2.2 ppb to
2.2 ppm, whereas general levels of PCBs in
soil and sediment are in the range of parts
per billion, and in water in subparts per tril-
lion (35). PCBs are found consistently in
many environmental matrices, including
marine plants and animals, freshwater ﬁsh,
mammals, wildlife, soils, air, and water. For
example, the estimated contents of PCBs in
samples of carp and pike taken from the
Tisa, Sava, and Danube rivers in Europe
were in the range of 9–25 ppb and 11–37
ppb, respectively (36). Because the allowed
concentrations of PCBs in food samples are
in the 0.3–5 ppm range (35), the sensitivity
of testicular androgenesis to PCB mixture in
the subnanomolar to nanomolar concentra-
tion ranges is of potential importance for
environmental contamination and altered
reproductive function.
On the other hand, the two commonly
used substitute transformer fluids, DC561
and ENOL C, did not affect rat testicular
steroidogenesis. Mineral oils are complex mix-
tures of oliphatic hydrocarbons, naphthenic,
and aromatics, the relative distribution of
which depends on the source of the oil and
method of reﬁnement (37). In general, the
belief that such composition should not be
toxic is consistent with our results. However,
used and recycled mineral oils exhibit muta-
genic and carcinogenic effects (37,38). It
would be of interest to compare the effects of
used and nonused samples of silicone- and
mineral oil-based transformer fluids on rat
testicular steroidogenesis. Also, it is possible
that such ﬂuids have different target mecha-
nisms compared to PCBs.
In summary, this study indicates that the
Aroclor 1260 based-transformer fluid
Askarel inhibits rat testicular steroidogenesis
after in vivo and in vitro applications.
3β HSD activity is inhibited by Askarel when
added in vitro or itt-injected, but is not
affected when transformer fluid is injected
ip. The effect of Askarel on P450c17 activity
depended on the type of application; there is
inhibition after ip application, and even a
stimulatory effect after itt application and
when added in vitro. NADPH-P450 reduc-
tase activity was also slightly affected by
Askarel, as well as a step(s) before proges-
terone formation. In all experimental condi-
tions, Askarel and/or degradable metabolites
of this mixture inﬂuenced testicular steroido-
genesis. On the other hand, silicone oil- and
mineral oil-based transformer ﬂuids had no
acute effect on rat testicular steroidogenesis.
These findings provide a rationale for a
number of observations on the antigonadal
actions of PCBs and suggest that both
DC561 and ENOL C express no endocrine-
disrupting activity. 
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